First positronium imaging using $^{44}$Sc with the J-PET scanner: a case study on the NEMA-Image Quality phantom
Authors:
Manish Das,
Sushil Sharma,
Aleksander Bilewicz,
Jarosław Choiński,
Neha Chug,
Catalina Curceanu,
Eryk Czerwiński,
Jakub Hajduga,
Sharareh Jalali,
Krzysztof Kacprzak,
Tevfik Kaplanoglu,
Łukasz Kapłon,
Kamila Kasperska,
Aleksander Khreptak,
Grzegorz Korcyl,
Tomasz Kozik,
Karol Kubat,
Deepak Kumar,
Anoop Kunimmal Venadan,
Edward Lisowski,
Filip Lisowski,
Justyna Medrala-Sowa,
Simbarashe Moyo,
Wiktor Mryka,
Szymon Niedźwiecki
, et al. (19 additional authors not shown)
Abstract:
Positronium Lifetime Imaging (PLI), an emerging extension of conventional positron emission tomography (PET) imaging, offers a novel window for probing the submolecular properties of biological tissues by imaging the mean lifetime of the positronium atom. Currently, the method is under rapid development in terms of reconstruction and detection systems. Recently, the first in vivo PLI of the human…
▽ More
Positronium Lifetime Imaging (PLI), an emerging extension of conventional positron emission tomography (PET) imaging, offers a novel window for probing the submolecular properties of biological tissues by imaging the mean lifetime of the positronium atom. Currently, the method is under rapid development in terms of reconstruction and detection systems. Recently, the first in vivo PLI of the human brain was performed using the J-PET scanner utilizing the $^{68}$Ga isotope. However, this isotope has limitations due to its comparatively low prompt gamma yields, which is crucial for positronium lifetime measurement. Among alternative radionuclides, $^{44}$Sc stands out as a promising isotope for PLI, characterized by a clinically suitable half-life (4.04 hours) emitting 1157 keV prompt gamma in 100% cases after the emission of the positron. This study reports the first experimental demonstration of PLI with $^{44}$Sc, carried out on a NEMA-Image Quality (IQ) phantom using the Modular J-PET tomograph-the first plastic scintillators-based PET scanner.
△ Less
Submitted 8 June, 2025;
originally announced June 2025.
Positronium Imaging: History, Current Status, and Future Perspectives
Authors:
Paweł Moskal,
Aleksander Bilewicz,
Manish Das,
Bangyan Huang,
Aleksander Khreptak,
Szymon Parzych,
Jinyi Qi,
Axel Rominger,
Robert Seifert,
Sushil Sharma,
Kuangyu Shi,
William Steinberger,
Rafał Walczak,
Ewa Stępień
Abstract:
Positronium imaging was recently proposed to image the properties of positronium atoms in the patient body. Positronium properties depend on the size of intramolecular voids and oxygen concentration; therefore, they deliver information different and complementary to the anatomic, morphological, and metabolic images. Thus far, the mean ortho-positronium lifetime imaging has been at the center of re…
▽ More
Positronium imaging was recently proposed to image the properties of positronium atoms in the patient body. Positronium properties depend on the size of intramolecular voids and oxygen concentration; therefore, they deliver information different and complementary to the anatomic, morphological, and metabolic images. Thus far, the mean ortho-positronium lifetime imaging has been at the center of research interest. The first ex vivo and in vivo positronium lifetime images of humans have been demonstrated with the dedicated J-PET scanner enabling simultaneous registration of annihilation photons and prompt gamma from ${β^{+} γ}$ emitters. Annihilation photons are used to reconstruct the annihilation place and time while prompt gamma is used to reconstruct the time of positronium formation. This review describes recent achievements in the translation of positronium imaging into clinics. The first measurements of positronium lifetime in humans with commercial PET scanners modernized to register triple coincidences are reported. The in vivo observations of differences in ortho-positronium lifetime between tumor and healthy tissues and between different oxygen concentrations are discussed. So far, the positronium lifetime measurements in humans were completed with clinically available ${^{68}\text{Ga}}$, ${^{82}\text{Rb}}$, and ${^{124}\text{I}}$ radionuclides. Status and challenges in developing positronium imaging on a way to a clinically useful procedure are presented and discussed.
△ Less
Submitted 27 May, 2025; v1 submitted 18 March, 2025;
originally announced March 2025.
